Reactome | Active FLT3 phosphorylates CDKN1B

Active FLT3 phosphorylates CDKN1B

Stable Identifier

R-HSA-9699578

Type

Reaction [transition]

Species

Homo sapiens

Compartment

cytosol, plasma membrane

ReviewStatus

5/5

Locations in the PathwayBrowser

Expand all

General

SBML | | PDF

SVG | | PPTX | SBGN

Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout

Active FLT3 binds to the cyclin dependent kinase inihibitor CDKN1B (also known as p27 KIP1) and phosphorylates it at tyrosine 88. (Peschel et al, 2017). Phosphorylation at Y88 dislodges the 3-10 helix of CDKN1B from the active site of CDK2 or CDK4, thus paritally relieving CDKN1B-dependent inhibition (Grimmler et al. 2007). This enables CDK2 (and possibly CDK4) to phosphorylate CDKN1B on threonine residue T187, which is a prerequisite for ubiquitin-mediated degradation of CDKN1B (Montagnoli et al. 1999, Grimmler et al. 2007).

Literature References

PubMed ID	Title	Journal	Year
10323868	Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation Montagnoli, A, Fiore, F, Eytan, E, Carrano, AC, Draetta, GF, Hershko, A, Pagano, M	Genes Dev	1999
17254966	Cdk-inhibitory activity and stability of p27Kip1 are directly regulated by oncogenic tyrosine kinases Grimmler, M, Wang, Y, Mund, T, Cilensek, Z, Keidel, EM, Waddell, MB, Jäkel, H, Kullmann, M, Kriwacki, RW, Hengst, L	Cell	2007
28522571	FLT3 and FLT3-ITD phosphorylate and inactivate the cyclin-dependent kinase inhibitor p27^Kip1 in acute myeloid leukemia Peschel, I, Podmirseg, SR, Taschler, M, Duyster, J, Götze, KS, Sill, H, Nachbaur, D, Jäkel, H, Hengst, L	Haematologica	2017